Back to Search
BORISLAV MEANDZIJA, MD
MD
Addiction Psychiatry Physician
NPI: 1992857619Individual
Specialties, Licenses & Credentials
Psychiatry Physician
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
028496(CT)
Addiction Psychiatry PhysicianPrimary
Psychiatry & Neurology — Addiction Psychiatry
Code: 2084P0802X
028496(CT)
Research & Publications (7)
Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.
PMID 18796184·Int J Neuropsychopharmacol·2009
4-observational
A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
PMID 17587504·Addict Behav·2008
4-observational
A pilot study of naltrexone and BASICS for heavy drinking young adults.
PMID 18502591·Addict Behav·2008
8-other
Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
PMID 18482155·Alcohol Clin Exp Res·2008
2-rct
Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.
PMID 18072836·Psychol Addict Behav·2007
4-observational
A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.
PMID 16567607·Arch Intern Med·2006
2-rct
Naltrexone and nicotine patch smoking cessation: a preliminary study.
PMID 14750508·Nicotine Tob Res·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- CONNECTICUT MENTAL HEALTH CENTER, 34 PARK ST
NEW HAVEN, CT 06519 - Phone
- (203) 974-7417
Quick Facts
- NPI
- 1992857619
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 7
Are you this provider?
Claim Your Profile